The E3 ubiquitin ligase APC/C-Cdh1 maintains the G0/G1 state, and its inactivation is required for cell cycle entry. We reveal a novel role for Fas-associated protein with death domain (FADD) in the cell cycle through its function as an inhibitor of APC/C-Cdh1. Using real-time, single-cell imaging of live cells combined with biochemical analysis, we demonstrate that APC/C-Cdh1 hyperactivity in FADD-deficient cells leads to a G1 arrest despite persistent mitogenic signaling through oncogenic EGFR/KRAS. We further show that FADDWT interacts with Cdh1, while a mutant lacking a consensus KEN-box motif (FADDKEN) fails to interact with Cdh1 and results in a G1 arrest due to its inability to inhibit APC/C-Cdh1. Additionally, enhanced expression of FADDWT but not FADDKEN, in cells arrested in G1 upon CDK4/6 inhibition, leads to APC/C-Cdh1 inactivation and entry into the cell cycle in the absence of retinoblastoma protein phosphorylation. FADD's function in the cell cycle requires its phosphorylation by CK1α at Ser-194 which promotes its nuclear translocation. Overall, FADD provides a CDK4/6-Rb-E2F-independent "bypass" mechanism for cell cycle entry and thus a therapeutic opportunity for CDK4/6 inhibitor resistance.
Background: Malnutrition significantly impacts surgical outcomes yet is difficult to identify preoperatively. Few studies have investigated the association between comprehensive body composition assessment and malnutrition in males and females separately. This study evaluates sex-specific associations between preoperative imaging-derived body composition features and malnutrition in abdominal surgery patients. Methods: This cross-sectional study included patients who underwent a preoperative abdominal computed tomography scan and elective abdominal surgery at a single institution (2018–2021). A deep learning algorithm quantified five muscle groups and two fat depots from CT scans. Clinical malnutrition was diagnosed by registered dietitians using standardized criteria. Sex-specific associations between imaging features and malnutrition were evaluated using logistic regression. Results: Among 1143 patients, 20.2% had clinical malnutrition, with prevalence varying by procedure type (3.5–38.2%). Malnutrition was associated with reduced muscle volume for both sexes; however, myosteatosis was only associated with malnutrition in females. In males, malnutrition was associated with decreased psoas volume (OR: 0.58, 95% CI [0.41–0.82]), decreased quadratus lumborum volume (OR: 0.52, 95% CI [0.35–0.77]), and reduced erector spinae attenuation (OR 0.58, 95% CI [0.41–0.82]). In females, decreased psoas volume (OR 0.56, 95% CI [0.41–0.77]) and attenuation (OR 0.59, 95% CI [0.44–0.79]) were associated with malnutrition. Both sexes showed increased subcutaneous fat attenuation (males: OR 1.58, 95% CI [1.22–2.04]; females: OR 1.96, 95% CI [1.54–2.50]) and visceral fat attenuation (males: OR 1.43 95% CI [1.07–1.90]; females: OR 1.68 95% CI [1.29–2.20]) associated with malnutrition. Conclusions: Males and females exhibit distinct body composition features associated with clinical malnutrition. Comprehensive analysis of muscle and fat characteristics reveals these sex-specific relationships, providing foundational knowledge for future development of predictive tools to enable earlier identification of patients at higher nutrition-related surgical risk.
Structured Background: Malnutrition significantly impacts surgical outcomes yet is difficult to identify preoperatively. Few studies have investigated the association between comprehensive body composition assessment and malnutrition in males and females separately. This study evaluates sex-specific associations between preoperative imaging-derived body composition features and malnutrition in abdominal surgery patients. Methods: We retrospectively analyzed patients who underwent computed tomography (CT) scans and elective abdominal surgery at a single institution (2018-2021). Preoperative CT scans were assessed using deep learning to quantify five muscle groups and two fat depots. Malnutrition was diagnosed by registered dietitians using standardized criteria. Sex-specific associations with malnutrition were evaluated using logistic regression. Results: Among 1,143 patients (52% female), clinical malnutrition was diagnosed in 20.2% of patients, with prevalence varying by procedure type (3.5-38.2%). Malnutrition was associated with reduced muscle volume for both sexes; in contrast, malnutrition was associated with myosteatosis in 3 of 5 muscle groups for females only. In males, malnutrition was associated with decreased psoas volume (OR 0.59 SD, p<0.01), decreased quadratus lumborum volume (OR 0.59 SD, p<0.01), and reduced erector spinae attenuation (OR 0.66 SD, p=0.048). In females, decreased psoas volume (OR 0.55 SD, p<0.001) and attenuation (OR 0.64 SD, p<0.01) were associated with malnutrition. Both sexes demonstrated increased subcutaneous fat attenuation associated with malnutrition (males: OR 1.51 SD, p<0.01; females: OR 1.73 SD, p<0.001), while increased visceral fat attenuation (OR 1.4 SD, p=0.027) was associated with malnutrition only in females. Conclusions: Males and females differ in baseline body composition and features associated with clinical malnutrition. Comprehensive deep learning analysis of muscle and fat characteristics from cross-sectional imaging provides insight into the sex-specific relationships between body composition and malnutrition in the preoperative setting and provides an opportunity for early identification of patients with greater nutrition-related surgical risk.
Background: Clinical malnutrition affects one in five abdominal surgery patients and increases postoperative complications and mortality. Current screening occurs after admission, closing the window for preoperative nutritional intervention. No objective, scalable preoperative screening tool exists. Objective: To determine whether automated volumetric CT-based body composition analysis improves preoperative identification of surgical patients at risk for clinical malnutrition compared to clinical variables or single-slice imaging alone. Methods: Retrospective cohort study of adults undergoing elective abdominal surgery at a quaternary academic medical center (2018–2021) with a preoperative CT scan within 90 days and complete nutrition assessment. Clinical malnutrition was diagnosed by a registered dietitian using ASPEN/AND criteria. Three sex-stratified Elastic Net models were compared: (1) base clinical variables; (2) base plus L3 single-slice skeletal muscle index and attenuation; and (3) base plus comprehensive 3D volumetric quantification of five muscle groups and two fat depots. Discrimination (AUROC), calibration (Brier score), and clinical utility (decision curve analysis) were assessed via 10-fold cross-validation. Results: Among 1,143 patients (52.4% female; mean age 60.5 years), 231 (20.2%) were diagnosed with malnutrition. Malnourished patients had significantly higher complication rates (36.4% vs. 15.4%, p <0.001) and prolonged length of stay (45.9% vs. 16.4%, p <0.001). Critically, 27.2% of malnourished patients were not flagged as at-risk by the standard Malnutrition Screening Tool. The volumetric model (Model 3) achieved the highest discrimination (males: AUROC 0.808; females: 0.794) and best calibration (males: Brier 0.129; females: 0.124), significantly outperforming both the base model (males: p =0.004; females: p <0.001) and L3 model (males: p =0.019; females: p <0.001). L3 features modestly improved discrimination but paradoxically worsened calibration — an effect corrected by volumetric features. Sex-specific risk profiles differed markedly, with ASA classification dominating female models and demographic factors dominating male models. Conclusions: Automated volumetric CT body composition analysis significantly improves preoperative malnutrition risk identification, with sex-stratified models revealing distinct risk profiles. Leveraging imaging already obtained for surgical planning, this approach opens a preoperative window for nutritional intervention that current practice fails to utilize.
(250 words) Background: Glutamine addiction is a hallmark of aggressive tumors, yet glutaminase (GLS1) inhibitor CB-839 showed disappointing anti-tumor efficacy in clinical trials. L-5-[11C]-glutamine ([11C]glutamine) PET enables non-invasive assessment of glutamine metabolism in vivo, providing a tool to test mechanistic hypotheses, and identify tumors likely to respond to GLS1 inhibition: focusing on compartmentation of GLS1-derived glutamate, CB-839 impact on flux, and reciprocal glutamine synthesis. Methods: Glutaminolytic TNBC (HCC1806) and poorly glutaminolytic ER+ (MCF-7) xenograft mice with or without CB-839, underwent dynamic [11C]glutamine PET. HPLC quantified fractional radioactivity of [11C]glutamine, soluble metabolites ([11C]glutamate, [11C]CO2), and macromolecule-incorporated metabolites from blood and tumor. A four-tissue compartment model characterized GLS1 activity (k_GLS) and flux, glutamine synthetase activity (k_GS), and subcellular glutamate distribution by comparing single vs. dual glutamate pool models. Averaged tumor curves and HPLC-derived tumor metabolites were fit. Monte Carlo simulations assessed parameter estimation performance. Results: The single glutamate pool model showed high correlations between k_GLS and other parameters, yielding inflated k_GLS estimates. The dual glutamate pool model reduced correlations, improved k_GLS recovery, and yielded subcellular glutamate distributions consistent with in vitro measurements. In TNBC, k_GLS was 3-fold higher than ER+ tumors (non-overlapping 95% CI) with glutamate concentrated in the mitochondrial compartment. CB-839 reduced k_GLS in TNBC and depleted mitochondrial glutamate (non-overlapping 95% CI), though glutaminolytic flux showed no distinguishable change. ER+ tumors showed higher k_GS compared to TNBC. Conclusion: [11C]glutamine PET kinetic analysis reveals distinct glutamine metabolic phenotypes in breast cancer subtypes. Preserved glutaminolytic flux and cytosolic glutamate in TNBC provide mechanistic hypotheses for clinical failure of GLS1 inhibitors, informing ongoing studies.